ATA112186A - Verfahren zur herstellung neuer imidazo(4,5-b)chinolinderivate - Google Patents

Verfahren zur herstellung neuer imidazo(4,5-b)chinolinderivate

Info

Publication number
ATA112186A
ATA112186A AT0112186A AT112186A ATA112186A AT A112186 A ATA112186 A AT A112186A AT 0112186 A AT0112186 A AT 0112186A AT 112186 A AT112186 A AT 112186A AT A112186 A ATA112186 A AT A112186A
Authority
AT
Austria
Prior art keywords
producing new
new imidazo
chinoline derivatives
chinoline
derivatives
Prior art date
Application number
AT0112186A
Other languages
English (en)
Other versions
AT390257B (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to AT0168989A priority Critical patent/AT390953B/de
Publication of ATA112186A publication Critical patent/ATA112186A/de
Application granted granted Critical
Publication of AT390257B publication Critical patent/AT390257B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0112186A 1985-04-25 1986-04-25 Verfahren zur herstellung neuer imidazo(4,5-b)chinolin-derivate AT390257B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0168989A AT390953B (de) 1986-02-26 1989-07-12 Verfahren zur herstellung neuer imidazo(4,5-b) chinolin-2-thione

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (2)

Publication Number Publication Date
ATA112186A true ATA112186A (de) 1989-09-15
AT390257B AT390257B (de) 1990-04-10

Family

ID=27111398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0112186A AT390257B (de) 1985-04-25 1986-04-25 Verfahren zur herstellung neuer imidazo(4,5-b)chinolin-derivate

Country Status (32)

Country Link
US (1) US4668686A (de)
KR (1) KR940000828B1 (de)
CN (1) CN1016175B (de)
AT (1) AT390257B (de)
AU (1) AU592983B2 (de)
BE (1) BE904671A (de)
CA (1) CA1298836C (de)
CH (1) CH675722A5 (de)
CY (1) CY1641A (de)
DE (1) DE3614132A1 (de)
DK (3) DK164868C (de)
EG (1) EG18104A (de)
ES (3) ES8708229A1 (de)
FI (1) FI83316C (de)
FR (1) FR2581065B1 (de)
GB (1) GB2174987B (de)
GR (1) GR861086B (de)
HK (1) HK64492A (de)
HU (1) HU195813B (de)
IL (1) IL78581A0 (de)
IT (1) IT1215651B (de)
LU (1) LU86406A1 (de)
MY (1) MY102086A (de)
NL (1) NL8601053A (de)
NO (1) NO163406C (de)
NZ (1) NZ215885A (de)
OA (1) OA08242A (de)
PT (1) PT82460B (de)
SE (1) SE461468B (de)
SG (1) SG29092G (de)
SU (3) SU1450746A3 (de)
YU (1) YU46054B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
AU695301B2 (en) * 1993-07-06 1998-08-13 Pfizer Inc. Bicyclic tetrahydro pyrazolopyridines
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6664264B2 (en) * 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
MXPA06001669A (es) 2003-08-12 2006-04-28 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos.
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja) 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Cd5+b細胞リンパ腫の治療方法
EP1673087B1 (de) * 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy-substituierte imidazochinoline
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CN1906192A (zh) * 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (de) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazochinolinyl-, imidazopyridinyl- und imidazonaphthyridinylsulfonamide
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
CN101056877B (zh) * 2004-09-14 2010-06-09 诺华疫苗和诊断公司 咪唑并喹啉化合物
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ,インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
EP1846405A2 (de) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxim- und hydroxylaminsubstituierte imidazo-4,5-c-ringverbindungen und verfahren
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
DK2069352T5 (en) 2006-08-02 2017-04-03 Cytokinetics Inc SPECIFIC CHEMICAL UNITS, COMPOSITIONS AND PROCEDURES
EP2139478A4 (de) * 2007-03-30 2010-05-05 Cytokinetics Inc Bestimmte chemische entitäten, zusammensetzungen und verfahren
US10272082B2 (en) 2011-07-13 2019-04-30 Cytokinetics, Inc. Combination ALS therapy
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
FI861684A0 (fi) 1986-04-22
FI83316B (fi) 1991-03-15
DK80291A (da) 1991-04-30
PT82460B (pt) 1988-11-30
ES554336A0 (es) 1987-10-01
BE904671A (fr) 1986-10-24
DK165248C (da) 1993-03-22
DK81091A (da) 1991-05-01
DK165248B (da) 1992-10-26
YU116787A (en) 1988-04-30
FI83316C (fi) 1991-06-25
AU592983B2 (en) 1990-02-01
EG18104A (en) 1992-09-30
DK190986A (da) 1986-10-26
ES8801829A1 (es) 1988-02-16
NZ215885A (en) 1989-04-26
AU5641386A (en) 1986-10-30
KR860008177A (ko) 1986-11-12
CN1016175B (zh) 1992-04-08
SG29092G (en) 1992-05-15
GR861086B (en) 1986-09-01
MY102086A (en) 1992-03-31
ES8802521A1 (es) 1988-07-16
IT1215651B (it) 1990-02-22
SE461468B (sv) 1990-02-19
SU1450746A3 (ru) 1989-01-07
FR2581065A1 (fr) 1986-10-31
OA08242A (en) 1987-10-30
DK80291D0 (da) 1991-04-30
NL8601053A (nl) 1986-11-17
FR2581065B1 (fr) 1990-02-02
IL78581A0 (en) 1986-08-31
AT390257B (de) 1990-04-10
CN86102747A (zh) 1987-02-04
SE8601907L (sv) 1986-10-26
YU46054B (sh) 1992-12-21
DK190986D0 (da) 1986-04-24
CY1641A (en) 1992-11-06
ES557552A0 (es) 1988-07-16
DK165249C (da) 1993-03-22
GB8610037D0 (en) 1986-05-29
PT82460A (en) 1986-05-01
HK64492A (en) 1992-09-04
HU195813B (en) 1988-07-28
LU86406A1 (fr) 1986-11-05
DK164868B (da) 1992-08-31
FI861684L (fi) 1986-10-26
US4668686A (en) 1987-05-26
ES8708229A1 (es) 1987-10-01
SE8601907D0 (sv) 1986-04-24
SU1560056A3 (ru) 1990-04-23
IT8620206A0 (it) 1986-04-24
CA1298836C (en) 1992-04-14
CH675722A5 (de) 1990-10-31
NO163406C (no) 1990-05-23
NO861617L (no) 1986-10-27
HUT42089A (en) 1987-06-29
DE3614132A1 (de) 1986-11-27
DK81091D0 (da) 1991-05-01
DK164868C (da) 1993-01-11
ES557551A0 (es) 1988-02-16
KR940000828B1 (ko) 1994-02-02
NO163406B (no) 1990-02-12
SU1470192A3 (ru) 1989-03-30
DK165249B (da) 1992-10-26
GB2174987A (en) 1986-11-19
GB2174987B (en) 1989-08-02

Similar Documents

Publication Publication Date Title
ATA71183A (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
ATA115486A (de) Verfahren zur herstellung neuer antibiotischer makrolite
AT389302B (de) Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate
ATA376184A (de) Verfahren zur herstellung neuer polysubstituierter naphthalinderivate
ATA364384A (de) Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate
DE3687502D1 (de) Verfahren zur herstellung eines wasserundurchlaessigen stoffes.
HUT42089A (en) Process for preparing 1,2-dihydro-2h-imidazo/4,5-b/quinolin-2-one derivatives
AT386208B (de) Verfahren zur herstellung neuer carbapenemzwischenverbindungen
ATA165685A (de) Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate
ATA121486A (de) Verfahren zur herstellung neuer disubstituierter 1,4-piperazinylderivate
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA105085A (de) Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine
ATA231786A (de) Verfahren zur herstellung neuer antitumor-antibiotika
AT381104B (de) Verfahren zur herstellung neuer cyclopeptidderivate
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA310385A (de) Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate
ATA305785A (de) Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate
ATA332984A (de) Verfahren zur herstellung neuer 4-chloro substituierter furo-(3,4-c)-pyridinderivate
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
ATA323986A (de) Verfahren zur herstellung neuer 4-h-benzo(4,5)-cyclohepta(1,2-b)thiophenderivat
ATA257386A (de) Verfahren zur herstellung neuer brenzcatechinderivate
AT387576B (de) Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate
ATA260285A (de) Verfahren zur herstellung neuer 6-aminomethyl-furo-(3,4-c)-pyridinderivate
ATA215987A (de) Verfahren zur herstellung neuer chinazolinonverbindungen

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee